Dr Helen Castor has announced a series of pivotal findings from the latest phase of her research program, positioning her laboratory at the forefront of oncology innovation. The data, presented at the International Oncology Summit earlier this week, showcases unprecedented efficacy in targeted drug combinations and offers renewed hope for patients with hard‑to‑treat malignancies. Accelerated […] Read more…